PDF (1376K)
摘要
治疗性血浆置换是通过物理方式快速清除血液中的有害成分,同时补充血浆及/或白蛋白等外源性置换液,达到缓解症状、改善器官受损状态的方法。参与肾脏、血液、消化、免疫等多个系统疾病的治疗,在临床中应用广泛。本综述根据最新研究证据,总结血浆置换在血液疾病中的应用,重点阐述其在自身免疫性溶血性贫血、血栓性微血管病、高丙种球蛋白血症中的高黏血症、冷球蛋白血症等血液疾病中的临床治疗现状,分析其疗效特征、安全性管理及治疗方案的优化策略。同时探讨了血浆置换在血液疾病治疗中的局限性与未来发展方向,旨在为临床实践与学术研究提供参考。
Abstract
Objective Therapeutic plasma exchange (TPE) rapidly removes harmful substances from the blood by physical means, while replacing with exogenous fluids such as fresh frozen plasma and/ or albumin, thus alleviating clinical symptoms and mitigating organ injury. It is widely used in the treatment of renal, hematological, digestive, and immune-mediated diseases. This review summarizes the application of plasma exchange in hematological diseases based on the latest research evidence, focusing on its current clinical status in autoimmune hemolytic anemia, thrombotic microangiopathy, hyperviscosity syndrome secondary to hypergammaglobulinemia, and cryoglobulinemia. Based on recent evidence, we analyze its efficacy, safety management, and optimized therapeutic strategies. We also discuss the limitations and future directions of TPE in hematological diseases, aiming to provide a reference for clinical practice and research.
关键词
Key words
[Author(id=1329502153409135478, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=niun0129@163.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502153472050042, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, authorId=1329502153409135478, language=EN, stringName=Fang TAN, firstName=Fang, middleName=null, lastName=TAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Transfusion Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502153522381692, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, authorId=1329502153409135478, language=CN, stringName=谈芳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=陆军军医大学第二附属医院 输血科,重庆 400037, bio={"content":"谈芳(1990-),女,检验技师,Email:niun0129@163.com
"}, bioImg=null, bioContent=谈芳(1990-),女,检验技师,Email:niun0129@163.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502153333638001, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, xref=null, ext=[AuthorCompanyExt(id=1329502153350415218, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, companyId=1329502153333638001, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Transfusion Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China), AuthorCompanyExt(id=1329502153362998131, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, companyId=1329502153333638001, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=陆军军医大学第二附属医院 输血科,重庆 400037)])]), Author(id=1329502153568519039, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329502153631433602, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, authorId=1329502153568519039, language=EN, stringName=Yanni XIAO, firstName=Yanni, middleName=null, lastName=XIAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Transfusion Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502153677570948, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, authorId=1329502153568519039, language=CN, stringName=肖燕妮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=陆军军医大学第二附属医院 输血科,重庆 400037, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502153333638001, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, xref=null, ext=[AuthorCompanyExt(id=1329502153350415218, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, companyId=1329502153333638001, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Transfusion Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China), AuthorCompanyExt(id=1329502153362998131, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, companyId=1329502153333638001, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=陆军军医大学第二附属医院 输血科,重庆 400037)])]), Author(id=1329502153723708298, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=louise-r-q@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329502153786622862, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, authorId=1329502153723708298, language=EN, stringName=Qian RAN, firstName=Qian, middleName=null, lastName=RAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Transfusion Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329502153832760209, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, authorId=1329502153723708298, language=CN, stringName=冉茜, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=陆军军医大学第二附属医院 输血科,重庆 400037, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329502153333638001, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, xref=null, ext=[AuthorCompanyExt(id=1329502153350415218, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, companyId=1329502153333638001, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Transfusion Medicine, The Second Affiliated Hospital, Army Medical University, Chongqing 400037, China), AuthorCompanyExt(id=1329502153362998131, tenantId=1045748351789510663, journalId=1155139928303341785, articleId=1329407918358016750, companyId=1329502153333638001, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=陆军军医大学第二附属医院 输血科,重庆 400037)])])]
谈芳,肖燕妮,冉茜.
治疗性血浆置换在血液疾病中的临床应用[J].
中国输血杂志, 2026, 39(7): 977-984 DOI:10.13303/j.cjbt.issn.1004-549x.2026.07.024
| [1] |
REEVES H M, WINTERS J L. The mechanisms of action of plasma exchange[J].Br J Haematol, 2014, 164(3):342-351.
|
| [2] |
CONNELLY-SMITH L, ALQUIST C R, AQUINA, et al. Guidelines on the use of therapeutic apheresis in clinical practice -evidence-based approach from the writing committee of the American society for apheresis:the ninth special issue[J].J Clin Apher, 2023, 38(2):77-278.
|
| [3] |
ABE T, MATSUO H, ABE R, et al. The Japanese society for apheresis clinical practice guideline for therapeutic apheresis[J].Ther Apher Dial, 2021, 25(6):728-876.
|
| [4] |
HILL Q A, STAMPS R, MASSEY E, et al. The diagnosis and management of primary autoimmune haemolytic anaemia[J].Br J Haematol, 2017, 176(3):395-411.
|
| [5] |
LORIAMINI M, CSERTI-GAZDEWICH C, BRANCH D R. Autoimmune hemolytic anemias: classifications, pathophysiology, diagnoses and management[J].Int J Mol Sci, 2024, 25(8):4296.
|
| [6] |
HASHIMOTO C. Autoimmune hemolytic anemia[J].Clin Rev Allergy Immunol, 1998, 16(3):285-295.
|
| [7] |
BARCELLINI W. New insights in the pathogenesis of autoimmune hemolytic anemia[J].Transfus Med Hemother, 2015, 42(5):287-293.
|
| [8] |
DESTIVAL J B, URBINA T, BOUGOUIN W, et al. Severe autoimmune hemolytic anemia in ICU:a place for emergency plasma exchange? A French multicenter retrospective study[J].Crit Care, 2025, 29(1):412.
|
| [9] |
JÄGER U, BARCELLINI W, BROOME C M, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults:recommendations from the first international consensus meeting[J].Blood Rev, 2020, 41:100648.
|
| [10] |
DEBSKA-SLIZIEN A, CHAMIENIA A, KRÓL E, et al. Hemolytic anemia after renal transplantation:analysis of case reports[J].Transplant Proc, 2003, 35(6):2233-2237.
|
| [11] |
PELLETIER J, WARD C, BORLOZ M, et al. A case of childhood severe paroxysmal cold hemoglobinuria with acute renal failure successfully treated with plasma exchange and eculizumab[J].Case Rep Pediatr, 2022, 2022:3267189.
|
| [12] |
孟祎, 吴玉斌, 雷晔飞, 等. 血浆置换治疗儿童自身免疫性溶血性贫血疗效分析[J].中国小儿急救医学, 2022, 29(9):691-695.
|
| [13] |
MENG Y, WU Y B, LEI Y F, et al. Analysis of the efficacy of plasma exchange in the treatment of autoimmune hemolytic anemia in children[J].Chin Pediatr Emerg Med, 2022, 29(9):691-695.
|
| [14] |
王刚, 高旖鑫, 吴林燕, 等. 半全血置换治疗低体重儿童自身免疫性溶血性贫血并发溶血危象 1 例[J].临床输血与检验, 2025, 27(2):196-199.
|
| [15] |
WANG G, GAO Y X, WU L Y, et al. One case of autoimmune hemolytic anemia complicated with hemolytic crisis in low-weight children treated with semi-whole blood replacement[J].J Clin Transf Lab Med, 2025, 27(2):196-199.
|
| [16] |
王刚, 高旖鑫, 吴林燕, 等. 全血置换联合淋巴血浆置换治疗难治性自身免疫性溶血性贫血的临床疗效[J].中国输血杂志, 2025, 38(10):1348-1354.
|
| [17] |
WANG G, GAO Y X, WU L Y, et al. Clinical efficacy of whole blood replacement combined with lymphoplasmapheresis in the treatment of refractory autoimmune hemolytic anemia[J].Chin J Blood Transfusion, 2025, 38(10):1348-1354.
|
| [18] |
LI B J, YUAN X, JIANG Y J, et al. Retrospective analysis of 30 severe autoimmune hemolytic anemia patients treated by whole blood exchange transfusion[J].Transfusion, 2015, 55(9):2231-2237.
|
| [19] |
LEISRING J, BRODSKY S V, PARIKH S V. Clinical evaluation and management of thrombotic microangiopathy[J].Arthritis Rheumatol, 2024, 76(2):153-165.
|
| [20] |
戴艳玲,代思源,李晓照,等. 血栓性微血管病临床诊疗进展[J].中华医学杂志, 2018, 98 (48):3987-3990.
|
| [21] |
DAI Y L, DAI S Y, LI X Z, et al. Advances in clinical diagnosis and treatment of thrombotic microangiopathy[J].Natl Med J China, 2018, 98(48):3987-3990.
|
| [22] |
ZHENG X L, VESELY S K, CATALAND S R, et al. Good practice statements(GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura[J].J Thromb Haemost, 2020, 18(10):2503-2512.
|
| [23] |
JOLY B S, COPPO P, VEYRADIER A. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura[J].Expert Rev Hematol, 2019, 12(6):383-395.
|
| [24] |
SCULLY M, ANTUN A, CATALAND S R, et al. Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura[J].N Engl J Med, 2024, 390(17):1584-1596.
|
| [25] |
ALBANELL-FERNÁDEZ M, MONGE-ESCARTÍN I, CARCELERO-SAN MARTÍN E, et al. Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura:Case series[J].Transfus Apher Sci, 2023, 62 (3):103722.
|
| [26] |
VÖLKER L A, KAUFELD J, MIESBACH W, et al. Re-al-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura[J].Blood Adv, 2020, 4(13):3085-3092.
|
| [27] |
LZQUIERDO C P, MINGOT-CASTELLANO M E, FUENTES A E K, et al. Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura[J].Blood Adv, 2022, 6(24):6219-6227.
|
| [28] |
SULLIVAN S D, CHATURVEDI S, GAUTAM P, et al. Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States[J].J Manag Care Spec Pharm, 2025, 31(3):277-288.
|
| [29] |
PISHKO A M, LI A, CUKER A. Immune Thrombotic Thrombocytopenic Purpura:A Review[J].JAMA, 2025, 334(6):517-529.
|
| [30] |
KÜHNE L, KNÖBL P, ELLER K, et al. Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange[J].Blood, 2024, 144(14):1486-1495.
|
| [31] |
CERVANTES C E, BLOCH E M, SPERATI C J. Therapeutic plasma exchange:core curriculum 2023[J].Am J Kidney Dis, 2023, 81(4):475-492.
|
| [32] |
SZCZEPIORKOWSKI Z M. Indications for therapeutic apheresis in hematological disorders[J].Semin Hematol, 2020, 57(2):57-64.
|
| [33] |
RAVAL J S, MAZEPA M A, ROLLINS-RAVAL M A, et al. Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients[J].Transfusion, 2020, 60(8):1676-1680.
|
| [34] |
COPPO P, CUKER A, GEORGE J N. Thrombotic thrombocytopenic purpura:Toward targeted therapy and precision medicine[J].Res Pract Thromb Haemost, 2018, 3(1):26-37.
|
| [35] |
ZHENG X L, AL-HOUSNI Z, CATALAND S R, et al. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura[J].J Thromb Haemost, 2025, 23(11):3711-3732.
|
| [36] |
中华医学会血液学分会血栓与止血学组. 血栓性血小板减少性紫癜诊断与治疗中国指南(2022 年版)[J].中华血液学杂志, 2022, 43(1):7-12.
|
| [37] |
Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of thrombotic thrombocytopenic purpura (2022 edition)[J].Chin J Hematol, 2022, 43(1):7-12.
|
| [38] |
CATALAND S R, COPPO P, SCULLY M, et al. Thrombotic thrombocytopenic purpura:100 years of research on Moschcowitz syndrome[J].Blood, 2024, 144(11):1143-1152.
|
| [39] |
WINTROBE M M, BUELL M V. Hyperproteinemia associated with multiple myeloma:with report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud’ s disease[J].Bull Hopkins Hosp, 1933, 52:156-164.
|
| [40] |
CACOUB P, VIEIRA M, SAADOUN D. Cryoglobulinemia-one name for two diseases[J].N Engl J Med, 2024, 391(15):1426-1439.
|
| [41] |
SIDANA S, RAJKUMAR S V, DISPENZIERI A, et al. Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia[J].Am J Hematol, 2017, 92(7):668-673.
|
| [42] |
ZHANG L L, CAO X X, SHEN K N, et al. Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients:a single-center study of 45 patients[J].Ann Hematol, 2020, 99(8):1735-1740.
|
| [43] |
MUCHTAR E, MAGEN H, GERTZ M A. How I treat cryoglobulinemia[J].Blood, 2017, 129(3):289-298.
|
| [44] |
于晓霞,金凤兰,朱波. 冷球蛋白血症血浆置换治疗及护理体会[J].中西医结合护理(中英文), 2019, 5(11):96-98.
|
| [45] |
YU X X, JIN F L, ZHU B. Use of plasmapheresis in the management of patients withcryoglobulinemia and related nursing measures[J].Nurs Integr Tradit Chin West Med, 2019, 5(11):96-98.
|
| [46] |
QUARTUCCIO L, BORTOLUZZI A, SCIRÈ C A, et al. Management of mixed cryoglobulinemia with rituximab:evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)[J].Clin Rheumatol, 2023, 42(2):359-370.
|
| [47] |
KILLEEN R B, AWAIS M, MIKES B A. Cryoglobulinemia[S]. In:StatPearls. Treasure Island(FL):StatPearls Publishing, March 28, 2025.
|
| [48] |
BEUVON C, MARTIN M, BAILLOU C, et al. Etiologies of Polyclonal Hypergammaglobulinemia: A scoping review[J].Eur J Intern Med, 2021, 90:119-121.
|
| [49] |
MINES I, AL-ABAYECHI A, KAUR S, et al. Hyper-viscosity Syndrome in Undifferentiated Connective Tissue Disease:A Diagnostic and Therapeutic Challenge[J].Cureus, 2024, 16(3):e55399.
|
| [50] |
BRIDOUX F, LEUNG N, NASR S H, et al. International Kidney and Monoclonal Gammopathy Research Group. Kidney disease in multiple myeloma[J].Presse Med, 2025, 54(1):104264.
|
| [51] |
FEEST T G, BURGE P S, COHEN S L. Successful treatment of myeloma kidney by diuresis and plasmaphoresis[J].Br Med J, 1976, 1(6008):503-504.
|
| [52] |
SULU C, YALıN S F, GÜRER T, et al. Renal recovery after acute kidney injury requiring urgent hemodialysis is not associated with improved survival of the patients with multiple myeloma[J].Ir J Med Sci, 2023, 192(2):757-763.
|
| [53] |
LEUNG N, RAJKUMAR S V. Multiple myeloma with acute light chain cast nephropathy[J].Blood Cancer J, 2023, 13(1):46-48.
|
| [54] |
BRIDOUX F, LEUNG N, BELMOUAZ M, et al. Management of acute kidney injury in symptomatic multiple myeloma[J].Kidney Int, 2021, 99(3):570-580.
|
| [55] |
DIMA D, GOEL U, SANNAREDDY A, et al. Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy[J].Hematol Oncol, 2024, 42(4):3293-3302.
|
基金资助
髓型急性放射综合征教育部医药基础研究创新中心开放项目-重点项目(ARSBIC-A-202401)
陆军军医大学第二附属医院学科优才一类项目(2023XKRC008)